Hypersensitivity 1 4

Embed Size (px)

Citation preview

  • 7/28/2019 Hypersensitivity 1 4

    1/62

    HYPERSENSITIVITY

  • 7/28/2019 Hypersensitivity 1 4

    2/62

    dr R. Lia K. Iswara, MS, SpMK (K)

  • 7/28/2019 Hypersensitivity 1 4

    3/62

    HYPERSENSITIVITY

    A damage to host mediated by

    preexisting an abnormalimmune response to self or

    foreign antigen

  • 7/28/2019 Hypersensitivity 1 4

    4/62

  • 7/28/2019 Hypersensitivity 1 4

    5/62

    Hypersensitivity (Allergy):Four Types of Hypersensitivity Reactions:

    Type I: Anaphylactic/Immediate Reactions

    Type II: Cytotoxic Reactions

    Type III: Immune Complex Reactions

    Type IV: Cell-Mediated/delayed Reactions

  • 7/28/2019 Hypersensitivity 1 4

    6/62

  • 7/28/2019 Hypersensitivity 1 4

    7/62

  • 7/28/2019 Hypersensitivity 1 4

    8/62

  • 7/28/2019 Hypersensitivity 1 4

    9/62

  • 7/28/2019 Hypersensitivity 1 4

    10/62

    Type I (Anaphylactic) ReactionsOccur within minutes of exposure to antigen

    Antigens combine with IgE antibodies

    IgE binds to mast cells and basophils, causingthem to undergo degranulationand release

    several mediators:

  • 7/28/2019 Hypersensitivity 1 4

    11/62

    Type I (Anaphylactic) ReactionsHistamine: Dilates and increases permeability of

    blood vessels (swelling and redness), increases

    mucus secretion (runny nose), smooth muscle

    contraction (bronchi).

    Prostaglandins: Contraction of smooth muscle of

    respiratory system and increased mucus secretion.

    Leukotrienes: Bronchial spasms.

    Anaphylactic shock: Massive drop in blood

    pressure. Can be fatal in minutes.

  • 7/28/2019 Hypersensitivity 1 4

    12/62

    Mast Cells and the Allergic Response

  • 7/28/2019 Hypersensitivity 1 4

    13/62

    Role of Mast Cells & Basophils

    Mast cells located in the connective tissue of

    all organs (in lungs, skin, GI and genital tract)

    Basophils circulate in blood into tissues

    Each cell can bind 10,000-40,000 IgE

    Cytoplasmic granules contain

    activecytokines, histamine, etc

    Cells degranulate when stimulated by allergen

  • 7/28/2019 Hypersensitivity 1 4

    14/62

    Chemical mediators

  • 7/28/2019 Hypersensitivity 1 4

    15/62

    Mast Cells and the Allergic Response

  • 7/28/2019 Hypersensitivity 1 4

    16/62

  • 7/28/2019 Hypersensitivity 1 4

    17/62

    Mechanism of Type I

    Sensitizing dose

    first contact with allergen(specific B cells form IgE which attaches tomast cells and basophils)

    Provocativedose - subsequent exposure withthe same allergen (binds to the IgE-mast cellcomplex)

    Degranulation : releases mediators withphysiological effects (vasodilation andbronchoconstriction)

    Symptoms : rash, itching, redness, increasedmucous discharge, pain, swelling, and difficultybreathing

  • 7/28/2019 Hypersensitivity 1 4

    18/62

  • 7/28/2019 Hypersensitivity 1 4

    19/62

  • 7/28/2019 Hypersensitivity 1 4

    20/62

  • 7/28/2019 Hypersensitivity 1 4

    21/62

  • 7/28/2019 Hypersensitivity 1 4

    22/62

  • 7/28/2019 Hypersensitivity 1 4

    23/62

    Systemic Anaphylaxis

    Sudden respiratory and circulatory

    disruption that can be fatal in a few

    minutesAllergen and route are variable

    Bee stings, antibiotics or serum injection

  • 7/28/2019 Hypersensitivity 1 4

    24/62

  • 7/28/2019 Hypersensitivity 1 4

    25/62

  • 7/28/2019 Hypersensitivity 1 4

    26/62

    Strategies for circumventing

    allergic attacks

  • 7/28/2019 Hypersensitivity 1 4

    27/62

    Blocking Ab

  • 7/28/2019 Hypersensitivity 1 4

    28/62

  • 7/28/2019 Hypersensitivity 1 4

    29/62

  • 7/28/2019 Hypersensitivity 1 4

    30/62

  • 7/28/2019 Hypersensitivity 1 4

    31/62

  • 7/28/2019 Hypersensitivity 1 4

    32/62

    Type II (Cytotoxic) ReactionsInvolve activation ofcomplement by IgG or

    IgM binding to an antigenic cell.

    Antigenic cell is lysed.

    Transfusion reactions:

    ABO Blood group system: Type O is universal

    donor. Incompatible donor cells are lysed as theyenter bloodstream.

  • 7/28/2019 Hypersensitivity 1 4

    33/62

    Type II (Cytotoxic) ReactionsRh Blood Group System: 85% of population is Rh

    positive. Those who are Rh negative can be

    sensitized to destroy Rh positive blood cells.

    Hemolytic disease of newborn: Fetal cells are destroyed

    by maternal anti-Rh antibodies that cross the placenta.

  • 7/28/2019 Hypersensitivity 1 4

    34/62

    Immunopathology

    Definition - Type II reaction

    Cytotoxic antibodies of IgM or IgG

    subtype formed against an antigen on a

    cell surface, or more rarely, against a

    component of the extracellular matrix.

    Usually, the binding of the antibody to the

    cellular antigen causes complement

    fixation (activation).

    The membrane attack complex (MAC) of

    complement then kills the cell.

  • 7/28/2019 Hypersensitivity 1 4

    35/62

  • 7/28/2019 Hypersensitivity 1 4

    36/62

  • 7/28/2019 Hypersensitivity 1 4

    37/62

  • 7/28/2019 Hypersensitivity 1 4

    38/62

  • 7/28/2019 Hypersensitivity 1 4

    39/62

    Type III (Immune Complex) ReactionsInvolve reactions against solubleantigens

    circulating in serum.

    Antibody-Antigen immune complexes are

    deposited in organs, activate complement, and

    cause inflammatory damage.

    Glomerulonephritis: Inflammatory kidneydamage.

    Occurs with slightly high antigen-antibody

    ratio is present.

  • 7/28/2019 Hypersensitivity 1 4

    40/62

    Immunopathology

    Definition - Type III reaction

    Type III reactions involve immunecomplexes of antibody and antigen.

    Antibodies are of IgM or IgG type, but theantigen is usually a soluble antigen.

    Antibodies form immune complexes withthese antigens, and the complexes aredeposited in tissue activatecomplement.

    Kidney and skin are most often affected.

  • 7/28/2019 Hypersensitivity 1 4

    41/62

    Immunopathology

    Type III hypersensitivity reaction

    Immune complexes of ideal size areusually formed with slight antigen excess.

    Larger complexes removed by themononuclear phagocyte system.

    Complexes likely induce disease byattaching to the Fc or C3b receptors onpolymorphs, and trigger release ofcytokines, attracting more PMNs, andinitiating more complement fixation.

  • 7/28/2019 Hypersensitivity 1 4

    42/62

  • 7/28/2019 Hypersensitivity 1 4

    43/62

    Immune Complex Mediated Hypersensitivity

  • 7/28/2019 Hypersensitivity 1 4

    44/62

  • 7/28/2019 Hypersensitivity 1 4

    45/62

  • 7/28/2019 Hypersensitivity 1 4

    46/62

  • 7/28/2019 Hypersensitivity 1 4

    47/62

  • 7/28/2019 Hypersensitivity 1 4

    48/62

    SYSTEMIC LUPUS ERYTHEMATOSUS

    Detection of immune complexes in serum

  • 7/28/2019 Hypersensitivity 1 4

    49/62

    Detection of immune complexes in serum

  • 7/28/2019 Hypersensitivity 1 4

    50/62

    Type IV (Cell-Mediated) ReactionsInvolve reactions by TD memory cells.

    First contact sensitizes person.

    Subsequent contacts elicit a reaction.

    Reactions are delayedby one or more days

    (delayed type hypersensitivity).

    Delay is due to migration of macrophages and Tcells to site of foreign antigens.

  • 7/28/2019 Hypersensitivity 1 4

    51/62

    Type IV (Cell-Mediated) Reactions

    Reactions are frequently displayed on the skin:

    itching, redness, swelling, pain. Tuberculosis skin test

    Poison ivy

    Metals

    Latex in gloves and condoms (3% of health care workers)

    Anaphylactic shock may occur.

  • 7/28/2019 Hypersensitivity 1 4

    52/62

    Type IV Hypersensitivity

    Cell-mediated

    A delayed response to Ag involvingactivation of and damage by T cells

    Delayed allergic response

    skin responseto allergens tuberculin skin test, contactdermititis from plants, metals, cosmetics

    Graft rejection

    reaction of cytotoxic Tcells directed against foreign cells of agrafted tissue; involves recognition offoreign HLA

  • 7/28/2019 Hypersensitivity 1 4

    53/62

    ImmunopathologyTransplant rejection

    Mechanisms involved in transplant

    rejection

    T cell mediateddelayed type hypersensitivity

    Direct pathway via recipient CD4+ and CD8+

    recognition of MHC Class I antigens on donor APCs

    Indirect pathway whereby processing of antigen by

    the recipients APCs is required

    Antibody mediatedimmediate hypersensitivity

  • 7/28/2019 Hypersensitivity 1 4

    54/62

    Allergic Contact Dermatitis Response to

  • 7/28/2019 Hypersensitivity 1 4

    55/62

    Allergic Contact Dermatitis Response to

    Poison Ivy Hapten

  • 7/28/2019 Hypersensitivity 1 4

    56/62

    Contact dermatitis reaction to leather

  • 7/28/2019 Hypersensitivity 1 4

    57/62

  • 7/28/2019 Hypersensitivity 1 4

    58/62

    Granuloma in a leprosy

    i i i

  • 7/28/2019 Hypersensitivity 1 4

    59/62

    Delayed hypersensitivity

  • 7/28/2019 Hypersensitivity 1 4

    60/62

    Comparison of hypersensitivity

  • 7/28/2019 Hypersensitivity 1 4

    61/62

    Comparison of hypersensitivity

  • 7/28/2019 Hypersensitivity 1 4

    62/62